Menu
/REGISTER
Montecito
Tolman Wiker
Pac Premier
Fielding
Farmers merchants
Nixon Peabody
Express Pros
Loading...
You are here:  Home  >  Biotech  >  Current Article

Sientra’s third quarter losses worse than analysts expected

By   /   Tuesday, November 6th, 2018  /   Comments Off on Sientra’s third quarter losses worse than analysts expected

    Print       Email
Sales at Goleta breast implant manufacturer Sientra rose 72 percent to $16.9 million, according to a Nov. 6 report, but net losses mounted to $20.5 million for the third quarter, or 74 cents per share. The earnings missed analyst expectations of a 67 cent loss per share. The company reported that miraDry sales nearly tripled…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Invoca nets $56 million venture deal

Read More →